| CTNT 0.04 -10.11% | ALP 0.23 -17.86% | FFAI 0.4232 -20.44% | TZA 5.04 -1.95% | BYND 1.1 5.26% | SOXS 16.8 -7.69% | NVDA 202.5 1.31% | NOK 9.825 -5.53% | BITO 10.82 5.15% | INTC 65.27 -1.49% | POET 12.77 24.59% | NVTS 18.47 20.48% | AGPU 8.75 79.30% | BMNG 1.64 14.69% | QVCGA 0.447 11.06% | TQQQ 60.21 4.90% | ONDS 11.06 1.75% | PLUG 3.19 3.57% | ASBP 0.2224 13.01% | AAL 11.5 -2.29% | BURU 0.2811 8.03% | CGC 1.38 21.05% | SOXL 105.64 7.70% | MSOS 5.11 19.39% | SMR 13.58 16.37% | FRMI 5.86 15.81% | TSLA 387.51 0.28% | T 25.97 0.35% | SQQQ 54.73 -4.97% | MARA 11.84 5.43% | IBIT 44.75 5.27% | AMD 303.46 6.67% | TDTH 0.0774 3.48% | BMNR 23.31 7.37% | TSLL 12.93 0.47% | NVD 5.56 -2.63% | MU 487.48 8.48% | SOFI 19.06 1.22% | PLTR 152.62 4.56% | OPEN 5.43 -0.37% | AAPL 273.17 2.63% | GAME 0.6069 33.86% | GPUS 0.1712 11.17% | SPY 711.21 1.01% | BSX 64.87 8.99% | AKAN 10.21 214.15% | SPDN 9.11 -0.98% | GRAB 4.06 -0.49% | BBD 4.04 -0.74% | CPNG 20.6 0.93%

US Foods Shares Climb 9% After Earnings Beat Despite Slight Revenue Miss

US Foods Holding Corp. (NYSE: USFD) reported fourth-quarter adjusted earnings that topped analyst expectations, although revenue came in marginally below forecasts. Shares advanced more than 9% intra-day Thursday following the announcement.

The foodservice distributor posted adjusted EPS of $1.04, exceeding the analyst consensus of $1.01.

Quarterly revenue reached $9.8 billion, marking a 3.3% increase year over year but falling short of the $9.94 billion analysts had projected. Total case volume grew 0.8% in the quarter, with independent restaurant case volume showing stronger growth of 4.1%.

Net income surged 178.8% to $184 million, while adjusted EBITDA rose 11.1% to $490 million. Adjusted EBITDA margin expanded 35 basis points to 5.0% compared to the prior-year quarter.

For full-year 2025, US Foods generated net sales of $39.4 billion, up 4.1% year over year, and net income rose 36.8% to $676 million.

Looking ahead to fiscal 2026, the company projected net sales growth of 4% to 6%, adjusted EBITDA growth of 9% to 13%, and adjusted diluted EPS growth of 18% to 24%. Management noted that fiscal 2026 will include a 53rd week, which is expected to contribute approximately 1% to total case growth and adjusted EBITDA growth.

Published on: February 12, 2026